Supplementary Table S3 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

<p>Supplementary Table S3 contains the list of genes that are significantly upregulated by both BCL2 inhibitor and Bcl2 knockout, as well as their link to the Type 1 IFN responses</p>